Biodesix (BDSX)
(Delayed Data from NSDQ)
$0.42 USD
+0.04 (10.10%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $0.46 +0.04 (8.75%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Biodesix, Inc. has a market cap of $56.31M, which represents its share price of $0.38 multiplied by its outstanding shares number of 146.56M. As a small-cap company, BDSX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BDSX 0.42 +0.04(10.10%)
Will BDSX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BDSX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BDSX
Avantor, Inc. (AVTR) Q2 Earnings Lag Estimates
Biodesix, Inc. (BDSX) Reports Q1 Loss, Misses Revenue Estimates
BDSX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Sonida Senior Living (SNDA) Reports Q1 Loss, Tops Revenue Estimates
DocGo Inc. (DCGO) Reports Q1 Loss, Misses Revenue Estimates
GeneDx Holdings Corp. (WGS) Q1 Earnings and Revenues Surpass Estimates
Other News for BDSX
Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference | BDSX Stock News
12 Health Care Stocks Moving In Friday's Pre-Market Session
Biodesix to Report Second Quarter 2025 Financial Results on August 7, 2025 | BDSX Stock News
12 Health Care Stocks Moving In Tuesday's After-Market Session
Biodesix (BDSX) Partners with APAPP to Enhance Lung Cancer Care | BDSX Stock News